Illumina

Senior Software Engineer

Singapore, Singapore, Singapore

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree and a minimum of 5 years of related experience, with a Master’s degree being acceptable, and should be proficient in Java, TypeScript, or another object-oriented language, along with experience in front-end technologies such as Angular, designing and developing object-oriented multi-threaded applications, building and consuming REST APIs, and utilizing RDBMS like AWS-RDS, PostgreSQL, or MySQL, as well as message queues like RabbitMQ or AWS-SQS.

Responsibilities

The Senior Software Engineer will work as part of Agile scrum teams to design, implement, and test world-class distributed cloud software, developing and maintaining Java-based web applications and microservices, evaluating and proposing suitable alternatives for software architecture, demonstrating a passion for clean code and architectures, leading joint design sessions, pair programming, and conducting design and code reviews, developing sustainable deployment and build processes, practicing software engineering principles, and striving to be a technical role model for the team while continuously learning and proactively identifying and suggesting solutions to problems.

Skills

Java
TypeScript
Angular
REST API
Microservices
Cloud Computing
Agile Methodologies
Scrum
Continuous Integration
Frontend Technologies
Backend Development
Software Design
Automated Deployment

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI